Segmed, Inc.

?? Join Segmed at RSNA 2024! ?? Discover how Segmed is transforming radiology and health innovation through real-world imaging data. At Segmed, we’re passionate about advancing patient care by enabling seamless access to diverse, de-identified imaging cohorts that streamline research, diagnostics, and treatment planning. 1?? Visit Us at Booth #5728 Explore the future of AI-driven Real-World Imaging Data in the AI Showcase Hall. Let’s discuss how Segmed can empower your work and revolutionize your approach to research and development. 2?? Don’t Miss Our AI Theater Presentation with Bayer Presentation: The data challenge for medical imaging AI development – how can we solve it? ?? When: Monday, December 2 at 3:30 PM CT ?? Where: RSNA AI Theater ?? Speakers: Martin Willemink, MD PhD FSCCT, Co-founder & CEO, Segmed Steffen Vogler, Principal Imaging Technology Scientist, AI Innovation Platform, Bayer We’ll tackle key questions around accessing and utilizing medical imaging data for AI development, followed by an interactive Q&A session. 3?? Cocktail Hour + RWiD Conversations Join us and Ingedata for an engaging happy hour to discuss how AI is shaping healthcare. Meet our executive team, network with industry experts, and share insights on AI-driven medical imaging innovations. ?? Date: Tuesday, December 3 from 3:00 PM - 5:00 PM CT Secure your spot by RSVPing?here: https://lnkd.in/eZWsGmxX Learn more at https://lnkd.in/dMxTecmM Let’s shape the future of radiology together. See you at RSNA! ?? #RSNA2024 #RadiologyInnovation #AIinHealthcare #Segmed

?? Thanks to Radiological Society of North America (RSNA) for highlighting our paper about #synthetic #medical #imaging! Lennart Koetzier; Jie Wu, PhD; Domenico Mastrodicasa; Aline Lutz, MD PhD; Matthew Chung; Adam Koszek; Jayanth Pratap; Akshay Chaudhari; Pranav Rajpurkar; Matthew Lungren MD MPH Segmed, Inc.; University of Washington - Department of Radiology; Harvard University; Stanford Radiology; Microsoft for Healthcare

Thank you RYVER.AI for hosting us and to all the attendees who joined our recent webinar on this critical topic! Medical AI has immense potential to transform healthcare, but achieving reliable outcomes depends on diverse, high-quality data. During the session, we explored key challenges and innovative solutions with experts who are leading this important work. If you missed it, catch up on the full conversation — link in the comments! #Segmed #MedicalAI #SyntheticData #HealthcareInnovation #BiasInAI #MedicalImaging #AIinHealthcare

? Last Chance to Join Us! ? The countdown is on! Don’t miss your chance to be part of our must-attend webinar on November 5th: “Tackling Bias in Medical Imaging AI with Synthetic Data.” Join Segmed and RYVER.AI along with special guest Geraldine McGinty MD, MBA, FACR from Weill Cornell Medicine and former Chair of the ACR Board of Chancellors, Martin Willemink, MD PhD FSCCT CEO and Cofounder from Segmed and Kathrin Khadra CTO from RYVER.AI, as we dive into how synthetic data is reshaping medical AI, reducing bias, and improving diagnostic accuracy across diverse patient populations. ?? Limited spots remain! Secure your place today to learn how we’re advancing AI in healthcare and pushing the boundaries of innovation. ?? Register NOW: https://hubs.li/Q02WxQ550 ?? Date: November 5th ?? Time: 18:00 CET / 12:00 EST #HealthcareAI #SyntheticData #MedicalImaging #Webinar #FinalCall #LastChance #Segmed

?? AI Transformation in Medical Imaging With the rise of AI in healthcare, ensuring that these systems reflect the diversity of the real world is crucial. That’s why Segmed is excited to partner with RYVER.AI to develop a cutting-edge AI model that will generate synthetic medical images from diverse populations. This initiative will help fill gaps in underrepresented patient groups and medical conditions, enhancing the accuracy and reliability of AI diagnostics. Learn more about the future of AI in healthcare by joining our joint webinar on November 5, with Geraldine McGinty MD, MBA, FACR from Weill Cornell Medicine and former Chair of the @ACR Board of Chancellors, our CEO and Cofounder Martin Willemink, MD PhD FSCCT and Kathrin Khadra CTO from Ryver.AI ?? Secure your spot today! https://hubs.li/Q02WlQZr0 #AI #HealthcareInnovation #SyntheticData #RealWorldData #MedicalImaging #WebinarInvite #Segmed

CTAD 2024 in full swing! Let’s Connect and discuss the future of Alzheimer’s disease research and usage of imaging data Segmed is thrilled to be here at the #CTAD 2024 conference in Madrid. Our curated, fit-for-purpose regulatory grade datasets and multimodal longitudinal datasets can transform how the pharma and biotech industry innovate. Whether it’s for external control arms, algorithm development, or real-world evidence generation, our datasets offer unparalleled depth for advancing research and therapeutic approaches in Oncology, Neurology and Cardiology in particular about Alzheimer’s research. If you’re at the conference, you can stop by and meet Kristin Yakimow, Chief Strategy Officer and discuss how our data can help you reach your next milestone! Alternative you can schedule for a one on one conversation here - https://hubs.li/Q02W1Xf70 #CTAD2024 #AlzheimersResearch #RWE #RealWorldImagingData #RWD #Imaging #ClinicalTrials #Segmed #research #RWiD #Realworldevidence #Realworlddata #Neurology #Neurodegenerativediseases #Research

CTAD 2024 in full swing! Let’s Connect and discuss the future of Alzheimer’s disease research and usage of imaging data Segmed is thrilled to be here at the #CTAD 2024 conference in Madrid. Our curated, fit-for-purpose regulatory grade datasets and multimodal longitudinal datasets can transform how the pharma and biotech industry innovate. Whether it’s for external control arms, algorithm development, or real-world evidence generation, our datasets offer unparalleled depth for advancing research and therapeutic approaches in Oncology, Neurology and Cardiology in particular about Alzheimer’s research. If you’re at the conference, you can stop by and meet Kristin Yakimow, Chief Strategy Officer and discuss how our data can help you reach your next milestone! Alternative you can schedule for a one on one conversation here - https://hubs.li/Q02W1Xf70 #CTAD2024 #AlzheimersResearch #RWE #RealWorldImagingData #RWD #Imaging #ClinicalTrials #Segmed #research #RWiD #Realworldevidence #Realworlddata #Neurology #Neurodegenerativediseases #Research

?? Exciting webinar coming up next week! In #healthcare, the #quality and #diversity of data are critical for building effective #AI models. At Segmed, Inc., we are now partnering with RYVER.AI aiming to revolutionize medical imaging AI by creating #synthetic images based on real-world imaging from Segmed's extensive data network. By integrating synthetic and real-world data, we're helping to ensure AI models are not only accurate but also inclusive — reflecting the diverse patient populations needed for robust diagnostics. Want to learn how synthetic data can effectively address biases and insufficient labelling in your proprietary imaging RWD? Join us on November 5 for our webinar: "Tackling Bias in Medical Imaging AI with Synthetic Data", where I will present along with: - Geraldine McGinty MD, MBA, FACR from Weill Cornell Medicine - Kathrin Khadra, CTO of RYVER.AI ?? When? Tuesday, 5th of November ? Time? 9:00am PST | 12:00 pm EST?I?6:00 pm CET ? Sign up for free access: LINK IN THE COMMENTS #MedicalImaging #Radiology #GenAI #Partnership #Innovation #DiversityInData #Inclusion #RWiD #Segmed #RyverAI

We’re Exhibiting at RSNA 2024 – Let’s Connect! Join us in Chicago at McCormick Place from Dec. 1–4, 2024, for an in-person experience where our expert team will be available to discuss new opportunities, answer your questions, and provide live demonstrations of our latest innovations on Real-World Imaging Data. ?? Find us at booth #5728 ?? Schedule a meeting here: https://hubs.li/Q02W1_Vm0 Whether you’re looking to optimize your research, unlock new insights, or simply network, we’d love to connect! #RSNA2024 #Radiology #HealthcareInnovation #MedicalImaging #HealthTech #AIinHealthcare #DataScience #HealthIT #MedicalConference #Networking

CTAD (Clinical Trials on Alzheimer's Disease) is starting today, and we couldn’t be more excited to learn and share insights on advancement in Alzheimer's research. As a leader in real-world imaging data, our datasets have been instrumental to organizations in supporting FDA-approved algorithms, aiding in biomarker identification and analysis, facilitating patient recruitment, and serving as an external control arm. Our datasets can significantly improve clinical trials and expedite the development of new treatments for Alzheimer's and other neurodegenerative diseases. Looking forward to connecting with thought leaders and innovators in the Alzheimer's research space. See you in Madrid! Our Chief Strategy Officer - Kristin Yakimow will be at the conference from tomorrow October 30 to November 1. To schedule a meeting - https://hubs.li/Q02W1Mw20 To learn more about Segmed and how we can collaborate to help you reach your goals and develop innovative solutions - https://hubs.li/Q02W1KtS0 #CTAD2024 #AlzheimersResearch #RWE #RealWorldImagingData #RWD #Imaging #ClinicalTrials #Segmed #research #RWiD #Realworldevidence #Realworlddata #Neurology #Neurodegenerativediseases #Research